| __timestamp | Amphastar Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 3243000 |
| Thursday, January 1, 2015 | 174172000 | 2472000 |
| Friday, January 1, 2016 | 150976000 | 2548000 |
| Sunday, January 1, 2017 | 149380000 | 19623000 |
| Monday, January 1, 2018 | 187681000 | 30421000 |
| Tuesday, January 1, 2019 | 190434000 | 32793999 |
| Wednesday, January 1, 2020 | 206506000 | 28304000 |
| Friday, January 1, 2021 | 238029000 | 620000 |
| Saturday, January 1, 2022 | 250127000 | 755000 |
| Sunday, January 1, 2023 | 293274000 | 1322000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. Amphastar Pharmaceuticals, Inc. has shown a consistent upward trend in its cost of revenue from 2014 to 2023, with a notable increase of approximately 84% over this period. This growth reflects the company's expanding operations and market reach. In contrast, Viridian Therapeutics, Inc. experienced a more volatile trajectory. After peaking in 2019, their cost of revenue saw a dramatic decline, dropping by nearly 96% by 2021. This stark contrast highlights the differing strategic paths and market challenges faced by these companies. Amphastar's steady growth suggests a robust operational strategy, while Viridian's fluctuations may indicate strategic pivots or market pressures. As the pharmaceutical industry continues to adapt to global demands, these insights provide a window into the financial health and strategic directions of key players.
Cost Insights: Breaking Down Merck & Co., Inc. and Viridian Therapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: Pfizer Inc. and Viridian Therapeutics, Inc.
Amgen Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Viridian Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs Viridian Therapeutics, Inc.
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Xenon Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.'s Expenses
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Evotec SE
Analyzing Cost of Revenue: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.
Analyzing Cost of Revenue: Evotec SE and Viridian Therapeutics, Inc.